Alseres Pharmaceuticals, Inc. focuses on developing diagnostic and therapeutic products primarily for disorders in the central nervous system. Its lead product candidate is Altropane, a molecular imaging agent for the diagnosis of Parkinson's disease and dementia. The company was formerly known as Boston Life Sciences, Inc. and changed its name to Alseres Pharmaceuticals, Inc. in June 2007. Alseres Pharmaceuticals, Inc. was founded in 1972 and is based in Auburndale, Massachusetts.
Show more...
FAQ
Alseres Pharmaceuticals 今天的股价是多少?▼
ALSE 当前价格为 $0.01 USD,过去 24 小时上涨了 +0%。在图表上更密切关注 Alseres Pharmaceuticals 股价表现。
Alseres Pharmaceuticals 的股票代码是什么?▼
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Alseres Pharmaceuticals 的股票以代码 ALSE 进行交易。
Alseres Pharmaceuticals 上一季度的财报怎么样?▼
ALSE 上季度财报为每股 -52.39 USD,预估为 不适用 USD,带来 不适用 的意外。下季度预估财报为每股 不适用 USD。
Alseres Pharmaceuticals 有多少名员工?▼
截至四月 01, 2026,公司共有3名员工。
Alseres Pharmaceuticals 属于哪个行业?▼
Alseres Pharmaceuticals从事于Professional, Scientific, and Technical Services行业。
Alseres Pharmaceuticals 何时完成拆股?▼
Alseres Pharmaceuticals 最近没有进行任何拆股。
Alseres Pharmaceuticals 的总部在哪里?▼
Alseres Pharmaceuticals 的总部位于 US 的 Auburndale。